Literature DB >> 2527565

Secondary structure of detergent-solubilized phospholamban, a phosphorylatable, oligomeric protein of cardiac sarcoplasmic reticulum.

H K Simmerman1, D E Lovelace, L R Jones.   

Abstract

The structure of phospholamban, a 30-kDa oligomeric protein integral to cardiac sarcoplasmic reticulum, was probed using ultraviolet absorbance and circular dichroism spectroscopy. Purified phospholamban was examined in three detergents: octyl glucoside, n-dodecyloctaethylene glycol monoether (C12E8) and sodium dodecyl sulfate (SDS). Ultraviolet absorption spectra of phospholamban reflected its aromatic amino acid content: absorption peaks at 275-277 nm and 253, 259, 265 and 268 nm were attributed to phospholamban's one tyrosine and two phenylalanines, respectively. Phospholamban phosphorylated at serine 16 by the catalytic subunit of cAMP-dependent protein kinase exhibited no absorbance changes when examined in C12E8 or SDS. Circular dichroism spectroscopy at 250-190 nm demonstrated that phospholamban possesses a very high content of alpha-helix in all three detergents and is unusually resistant to denaturation. Dissociation of phospholamban subunits by boiling in SDS increased the helical content, suggesting that the highly ordered structure is not dependent upon oligomeric interactions. The purified COOH-terminal tryptic fragment of phospholamban, containing residues 26-52 and comprising the hydrophobic, putative membrane-spanning domain, also exhibited a circular dichroism spectrum characteristic of alpha-helix. Circular dichroism spectra of phosphorylated and dephosphorylated phospholamban were very similar, indicating that phosphorylation does not alter phospholamban secondary structure significantly. The results are consistent with a two-domain model of phospholamban in which each domain contains a helix and phosphorylation may act to rotate one domain relative to the other.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2527565     DOI: 10.1016/0167-4838(89)90203-3

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  14 in total

1.  Locating phospholamban in co-crystals with Ca(2+)-ATPase by cryoelectron microscopy.

Authors:  H S Young; L R Jones; D L Stokes
Journal:  Biophys J       Date:  2001-08       Impact factor: 4.033

2.  Computational design of a water-soluble analog of phospholamban.

Authors:  Avram M Slovic; Christopher M Summa; James D Lear; William F DeGrado
Journal:  Protein Sci       Date:  2003-02       Impact factor: 6.725

3.  Monoclonal antibodies for dystrophin analysis. Epitope mapping and improved binding to SDS-treated muscle sections.

Authors:  T M Nguyen; I B Ginjaar; G J van Ommen; G E Morris
Journal:  Biochem J       Date:  1992-12-01       Impact factor: 3.857

4.  Comparing the structure and dynamics of phospholamban pentamer in its unphosphorylated and pseudo-phosphorylated states.

Authors:  Kirill Oxenoid; Amanda J Rice; James J Chou
Journal:  Protein Sci       Date:  2007-09       Impact factor: 6.725

5.  Using experimental information to produce a model of the transmembrane domain of the ion channel phospholamban.

Authors:  P Herzyk; R E Hubbard
Journal:  Biophys J       Date:  1998-03       Impact factor: 4.033

6.  A novel method for structure-based prediction of ion channel conductance properties.

Authors:  O S Smart; J Breed; G R Smith; M S Sansom
Journal:  Biophys J       Date:  1997-03       Impact factor: 4.033

7.  Structure of the 1-36 amino-terminal fragment of human phospholamban by nuclear magnetic resonance and modeling of the phospholamban pentamer.

Authors:  P Pollesello; A Annila; M Ovaska
Journal:  Biophys J       Date:  1999-04       Impact factor: 4.033

8.  Total synthesis and functional properties of the membrane-intrinsic protein phospholamban.

Authors:  T Vorherr; A Wrzosek; M Chiesi; E Carafoli
Journal:  Protein Sci       Date:  1993-03       Impact factor: 6.725

9.  Phospholamban and its phosphorylated form interact differently with lipid bilayers: a 31P, 2H, and 13C solid-state NMR spectroscopic study.

Authors:  Shadi Abu-Baker; Gary A Lorigan
Journal:  Biochemistry       Date:  2006-11-07       Impact factor: 3.162

10.  Characterization of the molecular form of cardiac phospholamban.

Authors:  J M Harrer; E G Kranias
Journal:  Mol Cell Biochem       Date:  1994-11-23       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.